Price $10.12 |
Market Cap
259.3M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
30.8
|
P/B
16.46
|
P/S
6.67
|
Dividend %
-
|
|
P/CF
73.8
|
P/FCF
66.6
|
Op. Cash Flow
6.8K
|
FCF
0.1
|
|
Op. Margin
25.00%
|
Net Margin
22.60%
|
ROE
70.90%
|
ROI
103.30%
|
|
ROA
43.30%
|
EPS Growth
-9.50%
|
Current Ratio
2.0
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Champions Oncology Inc (CSBR) | $8.24 | - | - | 94.6M | Strong Buy |
| Diversicare Healthcare Service (DVCR) | $2.26 | - | 10.00% | 14.7M | Strong Buy |
| NantHealth Inc (NH) | $1.36 | - | - | 113.9M | Strong Buy |
| CYANOTECH CORP (CYAN) | $2.40 | - | - | 13.6M | Strong Buy |
| Novelion Therapeutics Inc (USA (NVLNF) | $0.70 | - | - | 14.1M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
